Rockefeller Capital Management
ROIV icon

Rockefeller Capital Management’s Roivant Sciences ROIV Stock Holding History

Rockefeller Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
54,372
+115
+0.2% +$3.4K ﹤0.01% 1398
2026
Q1 		$1.5M Buy
54,257
+50,725
+1,436% +$1.3M ﹤0.01% 1424
2025
Q4 		$76.6K Sell
3,532
-294
-8% -$5.8K ﹤0.01% 2851
2025
Q3 		$57.9K Buy
+3,826
New +$47.4K ﹤0.01% 2835
2024
Q2 		– Sell
-28,215
Closed -$297K – 1716
2024
Q1 		$297K Buy
+28,215
New +$304K ﹤0.01% 1591
2023
Q1 		– Sell
-3,000
Closed -$23K – 3516
2022
Q4 		$23K Hold
3,000
– – ﹤0.01% 2757
2022
Q3 		$9K Hold
3,000
– – ﹤0.01% 3147
2022
Q2 		$12K Buy
+3,000
New +$11.9K ﹤0.01% 3028

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Rockefeller Capital Management's ROIV Position: Q2 2026 in Review

Rockefeller Capital Management increased its Roivant Sciences (ROIV) stake by 0.21% in Q2 2026, buying an estimated $3.4K and bringing the position to 54,372 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Rockefeller Capital Management first reported a position in ROIV in Q2 2022 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rockefeller Capital Management held 54,372 shares of Roivant Sciences worth $1.92M as of Q2 2026.
  • Rockefeller Capital Management bought 115 Roivant Sciences shares in Q2 2026, an estimated $3.4K.
  • Roivant Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1398 holding.
  • Rockefeller Capital Management first reported a position in Roivant Sciences in Q2 2022 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.